<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1802244939
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2018
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        PHOXILIUM 1.2MMOL/I SOL. FOR HAEMODIAL./HAEMOFILT
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        CALCIUM CHLORIDE,POTASSIUM CHLORIDE,SODIUM CHLORIDE,DISODIUM PHOSPHATE,MAGNESIUM CHLORIDE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        3.68,0.314,6.44,0.225,2.44
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        g/l
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Hemodialysis
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Solution for haemodialysis/haemofiltration
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        2
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Bag
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        18
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        Store between +4°C - +30°C , Do not refrigerate or freeze
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        128.8
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Gambro Dasco S.p.A " />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Gambro Dasco S.p.A 
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 360]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Farouk, Maamoun Tamer & CO
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            BAXTER HOLDING B.V
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        B05XA07 
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Phoxilium, belonging to the group of hemofiltrates solution, contains calcium chloride dihydrate, magnesium chloride hexahydrate, sodium chloride, sodium hydrogen carbonate, potassium chloride, disodium phosphate dihydrate.</p><p>&nbsp;</p><p>Phoxilium is used in hospitals in intensive care treatments to correct chemical imbalances in the blood which are caused by kidney injury.</p><p>&nbsp;</p><p><strong>The treatments</strong>, using continuous renal replacement therapy, are designed to remove accumulated waste products from the blood when the kidneys are not functioning.</p><p><strong>&nbsp;</strong></p><p><strong>The Phoxilium solution</strong> is particularly used to treat critically ill patients with acute kidney injury having:</p><p>&bull; a normal concentration of potassium in the blood <em>(normal kalaemia) </em>or</p><p>&bull; a normal or low concentration of phosphate in the blood <em>(normal or hypophosphataemia</em>).</p><p>&nbsp;</p><p>This medicine may also be used in case of drug poisoning or intoxications with dialysable or filterable substances.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not use Phoxilium in the following three cases:</strong></p><p>&bull; a high concentration of potassium in the blood <em>(hyperkalaemia)</em></p><p>&bull; a high concentration of bicarbonate in the blood <em>(metabolic alkalosis)</em></p><p>&bull; a high concentration of phosphate in the blood <em>(hyperphosphataemia)</em></p><p><strong>&nbsp;</strong></p><p><strong>Do not use haemodialysis or haemofiltration in any of the following three cases:</strong></p><p>&bull; when haemofiltration cannot correct the symptoms caused by a high blood concentration of urea <em>(uraemic symptoms) </em>which are the result of renal injury with pronounced hypercatabolism <em>(an abnormally increased process of breaking down substances)</em>,</p><p>&bull; insufficient arterial pressure in the access to the blood vessel,</p><p>&bull; reduced clotting of the blood <em>(systemic anticoagulation)</em>, if there is a high risk of bleeding.</p><p>&nbsp;</p><p>Warnings and precautions</p><p>Talk to your doctor or pharmacist or nurse before you are using Phoxilium.</p><p>&nbsp;</p><p>Before and during treatment, your blood condition will be checked, e.g. your acid-base balance and concentrations of salts in the blood <em>(electrolytes) </em>will be monitored, including all fluid inputs (intravenous infusion) and outputs (urine output), even those not directly related to the therapy.&nbsp;</p><p>&nbsp;</p><p>Other medicines and Phoxilium</p><p>Tell your doctor or pharmacist if you are using, have recently used or might use any other medicines. This is because the concentration of other medicines may influence the treatment with Phoxilium. Your doctor will decide if any changes in the dosage of your medicines should be made.</p><p>In particular, tell your doctor if you are using either of the following:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Additional sources of phosphate (e.g. nutritional fluids); as this may increase the risk of a high concentration of phosphate in the blood <em>(hyperphosphatemia).</em></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Vitamin D and medicinal products containing calcium chloride or calcium gluconate; as they can increase the risk of a high concentration of calcium in the blood <em>(hypercalcaemia)</em>.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Sodium bicarbonate; as this may increase the risk of excess of bicarbonate in your blood <em>(metabolic alkalosis).</em></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; When citrate is used as an anticoagulant, as it can reduce plasma calcium levels.</p><p>&nbsp;</p><p>Pregnancy, breast-feeding and fertility</p><p>Pregnancy and breast-feeding:</p><p>There is no documented clinical data on the use of this medicine during pregnancy and lactation. This medicine should only be administered to pregnant and lactating women if clearly needed.</p><p>&nbsp;</p><p>Fertility:</p><p>No effects on fertility are anticipated, since calcium, sodium, potassium, magnesium, chloride, hydrogen phosphate and hydrogen carbonate are normal constituents of the body.</p><p>&nbsp;</p><p>Driving and using machines</p><p>Phoxilium will not have any effect on the ability to drive or use machines.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Phoxilium is a product to be used in hospitals and administered by medical professionals only. The volume of Phoxilium, and therefore the dose, used will depend on your condition. The dose volume will be determined by the physician responsible for your treatment.</p><p>Phoxilium can be administered directly into the bloodstream <em>(intravenously)</em> through a CRRT machine<em> </em>or via haemodialysis, where the solution flows on one side of a dialysis membrane while the blood flows on the other side.</p><p>&nbsp;</p><p>Always use this medicine exactly as your doctor, pharmacist or nurse has told you. Check with your doctor, pharmacist or nurse if you are not sure. &nbsp;</p><p>&nbsp;</p><p>For instructions for use, please see section &ldquo;The following information is intended for healthcare professionals only&rdquo;.</p><p>&nbsp;</p><p><strong>If you use more Phoxilium than you should </strong></p><p>Phoxilium is a product to be used in hospitals and administered by medical professionals only and your fluid balance and blood chemistry will be carefully monitored.</p><p>&nbsp;</p><p><strong>Therefore it is unlikely that you will use more Phoxilium than you should </strong></p><p>In the unlikely event that an overdose occurs, your doctor will take the necessary corrective measures and adjust your dose.</p><p>Overdose may result in fluid overload, reduction of the plasma bicarbonate concentration (metabolic acidosis) and/or high phosphate concentration (hyperphosphataemia<em>)</em> if you are suffering from renal injury.</p><p>It could lead to severe consequences, such as congestive heart failure or disturbances in your blood chemistry.</p><p>&nbsp;</p><p>If you have any further questions on the use of this product, please ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.</p><p>The following three side effects <strong>related to the use of Phoxilium</strong> are possible:</p><p>&bull; abnormally high or low volume of water in the body <em>(hyper or hypovolaemia)</em>,</p><p>&bull; changes in levels of salt in the blood <em>(electrolyte </em><em>imbalance such as hyperphosphataemia)</em></p><p>&bull; Elevation of the plasma bicarbonate concentration (<em>metabolic alkalosis</em>) or reduction of the plasma bicarbonate concentration (<em>metabolic acidosis</em>).</p><p>&nbsp;</p><p>There are also some <strong>side effects</strong> which can be <strong>caused by </strong><strong>dialysis treatments</strong>, such as:</p><p>&bull; nausea, vomiting, muscle cramps and low blood pressure <em>(hypotension)</em>.</p><p>&nbsp;</p><p><strong><u>Reporting of side effects</u></strong></p><p>If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet.</p><p>You can also report side effects directly via the national reporting system listed below. By reporting side effects you can help provide more information on the safety of this medicine.</p><p>&nbsp;</p><p><strong>To report any side effect(s):</strong></p><p>&nbsp;</p><ul><li><strong>Saudi Arabia:</strong></li></ul><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0" style="width:588px"><tbody><tr><td style="vertical-align:top"><ul><li>The National Pharmacovigilance Centre (NPC)</li></ul><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SFDA Call Center: 19999</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; E-mail: npc.drug@sfda.gov.sa&nbsp;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Website: https://ade.sfda.gov.sa/ <u>&nbsp;</u>&nbsp;</p></td></tr></tbody></table><p>&nbsp;</p><ul><li><strong>United Arab Emirates:</strong></li></ul><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0" style="width:588px"><tbody><tr><td style="vertical-align:top"><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pharmacovigilance &amp; Medical Device section</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; P.O. Box: 1853</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tel: 80011111</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Email: pv@mohap.gov.ae</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Drug Department</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Ministry of Health &amp; Prevention</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dubai, UAE</p></td></tr></tbody></table><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Other GCC States:</strong></p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0" style="width:588px"><tbody><tr><td><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Please contact the relevant competent authority.</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep this medicine out of the sight and reach of children.</p><p>Do not use this medicine after the expiry date which is stated on the label and the packaging. The expiry date refers to the last day of that month.</p><p>Store between +4&deg;C and +30&deg;C. Do not refrigerate or freeze.</p><p>Chemical and physical in-use stability of the reconstituted solution has been demonstrated for 24 hours at 22&deg;C. If not used immediately in-use storage times and conditions prior to use are the responsibility of the user and should not be longer than 24 hours including the duration of the treatment.</p><p>Do not use this medicine if the solution is cloudy or the overwrap is damaged. All seals must be intact.</p><p>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>What Phoxilium contains.</strong></p><p>The active substances before and after mixing (reconstitution) are shown below.</p><p>&nbsp;</p><p><strong>Active substances before mixing:</strong></p><p>1000 ml of solution from the <strong>small compartment (A)</strong> contains:</p><p>Calcium chloride, 2 H<sub>2</sub>O &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3.68 g</p><p>Magnesium chloride, 6 H<sub>2</sub>O &nbsp; 2.44 g</p><p>&nbsp;</p><p>1000 ml of solution from the <strong>large compartment (B)</strong> contains:</p><p>Sodium chloride &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 6.44 g</p><p>Sodium hydrogen carbonate &nbsp; 2.92 g</p><p>Potassium chloride &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.314 g</p><p>Disodium phosphate, 2 H<sub>2</sub>O &nbsp; 0.225 g</p><p><strong>&nbsp;</strong></p><p><strong>Active substances after mixing:</strong></p><p>The solutions in the compartments A (250 ml) and B (4750 ml) are mixed to give one reconstituted solution (5000 ml) of which the composition is:</p><p>&nbsp;</p><p><strong>mmol/l</strong></p><p>Calcium, Ca<sup>2+</sup> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1.25</p><p>Magnesium, Mg<sup>2+ </sup>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.6</p><p>Sodium, Na<sup>+</sup> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 140</p><p>Chloride, Cl<sup>-</sup> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 115.9</p><p>Hydrogen phosphate, HPO<sub>4</sub><sup>2-</sup> 1.2</p><p>Hydrogen carbonate, HCO<sub>3</sub><sup>-</sup> &nbsp; 30</p><p>Potassium, K<sup>+</sup> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 4</p><p>&nbsp;</p><p>Theoretical Osmolarity: 293 mOsm/l</p><p>&nbsp;</p><p><strong>The other ingredients are:</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; carbon dioxide (for pH adjustment) E290,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; hydrochloric acid (for pH adjustment) E507 and</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; water for injections.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                What Phoxilium looks like and contents of the pack
Phoxilium is a solution for haemodialysis and haemofiltration presented in a two compartment bag. The final reconstituted solution is obtained after breaking the peel seal and mixing both solutions. The reconstituted solution is clear and colourless. Each bag (A+B) contains 5000 ml solution for haemodialysis and haemofiltration. The bag is overwrapped with a transparent film.
Each box contains two bags and one package leaflet.


            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Marketing Authorisation Holder:</strong></p><p><strong>Baxter Holding B.V.</strong></p><p>Kobaltweg 49</p><p>3542CE Utrecht</p><p>NEDERLAND</p><p>&nbsp;</p><p><strong>Manufacturer:</strong></p><p><strong>Bieffe Medital S.p.A.</strong></p><p>Via Stelvio 94</p><p>23035 Sondalo (SO)</p><p>ITALY</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last revised in March 2023
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">ينتمي فوكسيليوم إلى مجموعة محاليل ترشيح الدم، وھو يحتوي على كلورید الكالسیوم ثنائي ھیدرات، كلورید المغنیسیوم سداسي ھیدرات، كلورید الصودیوم، كلورید البوتاسیوم، كربونات ھیدروجین الصودیوم وثنائي الصوديوم فوسفات ثنائي الھيدرات.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&rlm; يستخدم فوكسيليوم في المستشفيات في الإجراءات العلاجية في وحدات العناية المركزة لتصحيح الاختلالات الكيميائية في الدم التي تسببھا إصابة الكلى.</p><p dir="RTL">&nbsp;</p><p dir="RTL">تم تصميم <strong>العلاجات</strong>، باستخدام البدائل المستمرة لوظائف الكلى، لإزالة النفايات المتراكمة من الدم عندما لا تعمل الكلى.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>محلول</strong><strong> </strong><strong>فوكسيليوم</strong> يستخدم بشكل خاص لعلاج المرضى ذوي الحالات الحرجة بإصابة الكلى الحادة ممن لديھم :</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تركيز طبيعي للبوتاسيوم في الدم، أو</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تركيز طبيعي أو منخفض للفوسفات في الدم .</p><p dir="RTL">&nbsp;</p><p dir="RTL">يمكن أيضًا استخدام هذا الدواء في حالة التسمم الدوائي أو التسمم بمواد قابلة للغسيل الكلوي أو قابلة للتنقية.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>لا تستخدم فوكسيليوم في الحالات</strong> <strong>الثلاث التالیة:</strong></p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التركيز العالي للبوتاسيوم في الدم ( فرط بوتاسيوم الدم ) ،</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التركیز العالي من البیكربونات في الدم (القلاء الأیضي).</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التركیز العالي من الفوسفات في الدم ( فَرط فوسفات الدم )</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>لا</strong> <strong>تستخدم</strong> <strong>الغسيل</strong> <strong>الدموي</strong> <strong>أو</strong> <strong>ترشيح</strong> <strong>الدم</strong> <strong>في</strong> <strong>أي</strong> <strong>من</strong> <strong>الحالات</strong> <strong>الثلاث</strong> <strong>التالية</strong> :</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عندما لا يكون ترشيح الدم قادراً على تصحيح الأعراض الناتجة عن ارتفاع تركيز اليوريا في الدم (أعراض اليوريمية) والتي تنتج عن الإصابات الكلوية بفرط التقويض الواضح (زيادة غير طبيعية في عملية تكسير المواد) ،</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الضغط الشریاني غیر كافٍ للوصول إلى الأوعیة الدمویة،</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض تخثر الدم (منع تخثر الدم الشامل)، إذا كان ھناك خطر كبیر من حدوث (نزیف).</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>اﻟﺘﺤﺬﯾﺮات واﻻﺣﺘﯿﺎطﺎت </strong></p><p dir="RTL">ﺗﺤﺪث إﻟﻰ طﺒﯿﺒﻚ أو اﻟﺼﯿﺪﻟﻲ أو اﻟﻤﻤﺮﺿﺔ ﻗﺒﻞ اﺳﺘﺨﺪام فوكسيليوم.</p><p dir="RTL">&nbsp;</p><p dir="RTL">ﻗﺒﻞ وأﺛﻨﺎء اﻟﻌﻼج، ﺳﯿﺘﻢ ﻓﺤﺺ ﺣﺎﻟﺔ دﻣﻚ، ﻋﻠﻰ ﺳﺒﯿﻞ اﻟﻤﺜﺎل، ﺳﯿﺘﻢ ﻓﺤﺺ وﻣﺮاﻗﺒﺔ ﺗﻮازن اﻟﻘﻮاﻋﺪ اﻟﺤﻤﻀﯿﺔ وﺗﺮﻛﯿﺰات اﻷﻣﻼح ﻓﻲ اﻟﺪم (اﻹﻟﻜﺘﺮوﻟﯿﺘﺎت)، ﺑﻤﺎ ﻓﻲ ذﻟﻚ ﺟﻤﯿﻊ اﻟﺴﻮاﺋﻞ اﻟﺘﻲ تأخذھا (اﻟﺘﺴﺮﯾﺐ اﻟﻮرﯾﺪي) واﻟﺘﻲ ﺗُﺨﺮﺟﮭﺎ (إﺧﺮاج اﻟﺒﻮل)، ﺣﺘﻰ ﺗﻠﻚ اﻟﺴﻮاﺋﻞ اﻟﺘﻲ ﻻ ﺗﺮﺗﺒﻂ ﻣﺒﺎﺷﺮة ﺑﺎﻟﻌﻼج.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>اﺳﺘﺨﺪام أدوﯾﺔ أﺧﺮى ﻣﻊ فوكسيليوم</strong></p><p dir="RTL">أﺧﺒﺮ طﺒﯿﺒﻚ أو اﻟﺼﯿﺪﻟﻲ إذا ﻛﻨﺖ ﺗﺄﺧﺬ، أو أﺧﺬت ﻣﺆﺧﺮًا أو ﻗﺪ ﺗﺄﺧﺬ أدوﯾﺔ أﺧﺮى.</p><p dir="RTL">وذﻟﻚ ﻷن ﻣﺴﺘﻮى ﺗﺮﻛﯿﺰ ﺑﻌﺾ اﻷدوﯾﺔ اﻷﺧﺮى اﻟﺘﻲ ﺗﺘﻨﺎوﻟﮭﺎ ﯾﻘﻞ ﻓﻲ اﻟﺪم أﺛﻨﺎء اﻟﻌﻼج. ﺳﻮف ﯾﻘﺮر اﻟﻄﺒﯿﺐ ﻣﺎ إذا ﻛﺎن ﯾﺠﺐ ﺗﻐﯿﯿﺮ اﻷدوﯾﺔ اﻷﺧﺮى.</p><p dir="RTL">&nbsp;</p><p dir="RTL">ﻋﻠﻰ وﺟﮫ اﻟﺨﺼﻮص، أﺧﺒﺮ طﺒﯿﺒﻚ إذا ﻛﻨﺖ ﺗﺴﺘﺨﺪم أﯾﺎً ﻣﻤﺎ ﯾﻠﻲ:</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مصادر إضافية للفوسفات (على سبيل المثال السوائل الغذائية)؛ لأن ھذا قد يزيد من خطر ارتفاع تركيز الفوسفات في الدم (فَرط فوسفات الدم).</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ﻓﯿﺘﺎﻣﯿﻦ د واﻟﻤﻨﺘﺠﺎت اﻟﻄﺒﯿﺔ اﻟﺘﻲ ﺗﺤﺘﻮي ﻋﻠﻰ اﻟﻜﺎﻟﺴﯿﻮم أو غلوكونات الكالسيوم، ﻷﻧﮭﺎ ﺗﺰﯾﺪ ﻣﻦ ﺧﻄﺮ ارتفاع تركيز الكالسيوم في اﻟﺪم (ﻓﺮط ﻛﺎﻟﺴﯿﻮم اﻟﺪم).</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أي مصدر إضافي لبيكربونات الصودیوم، لأن هذا قد یزید من خطر زیادة البیكربونات في الدم لدیك (القلاء الأیضي).</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عند استخدام السیترات كمضاد للتجلط، لأنھا یمكن أن تقلل من مستوى الكالسیوم في البلازما.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>اﻟﺤﻤﻞ واﻟﺮﺿﺎﻋﺔ اﻟﻄﺒﯿﻌﯿﺔ</strong> <strong>والخصوبة</strong></p><p dir="RTL">الحمل<em> </em>والرضاعة<em> </em>الطبيعية:</p><p dir="RTL">لا<em> </em>توجد<em> </em>بيانات<em> </em>سريرية<em> </em>موثقة<em> </em>حول<em> </em>استخدام<em> </em>ھذا<em> </em>الدواء<em> </em>أثناء<em> </em>الحمل<em> </em>والرضاعة. يتم<em> </em>إعطاء<em> </em>ھذا<em> </em>الدواء<em> </em>للنساء<em> </em>الحوامل والمرضعات<em> </em>فقط<em> </em>إذا<em> </em>لزم<em> </em>الأمر.</p><p dir="RTL">&nbsp;</p><p dir="RTL">الخصوبة:</p><p dir="RTL">من غير المتوقع حدوث أي تأثيرات على الخصوبة، لأن الكالسيوم والصوديوم والبوتاسيوم والمغنيسيوم والكلوريد وفوسفات الھيدروجين وكربونات الھيدروجين ھي مكونات طبيعية توجد في الجسم.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>اﻟﻘﯿﺎدة واﺳﺘﺨﺪام اﻵﻻت</strong></p><p dir="RTL">ﻟﻦ ﯾﻜﻮن فوكسيليوم أي ﺗﺄﺛﯿﺮ ﻋﻠﻰ اﻟﻘﺪرة ﻋﻠﻰ اﻟﻘﯿﺎدة أو اﺳﺘﺨﺪام اﻵﻻت.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">فوكسيليوم ھو منتج يتم استخدامه في المستشفيات ولا يتم إعطاؤه إلا من قبل المتخصصين في المجال الطبي فقط . كمية فوكسيليوم، وبالتالي الجرعة المستخدمة تعتمد على حالتك . سيتم تحديد حجم الجرعة من قبل الطبيب المسؤول عن علاجك.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يمكن إعطاء فوكسيليوم مباشرة في مجرى الدم (عن طريق الوريد) من خلال جھاز الغسيل الكلوي (CRRT) أو من خلال غسيل الكلى، حيث يتدفق المحلول على جانب واحد من غشاء غسيل الكلى بينما يتدفق الدم على الجانب الآخر.</p><p dir="RTL">&nbsp;</p><p dir="RTL">استخدم ھذا الدواء دائمًا وفقًا لما أخبرك به الطبیب أو الصیدلي. استشر طبیبك أو الصیدلي إذا كنت غیر متأكد.</p><p dir="RTL">&nbsp;</p><p dir="RTL">ﻟﻠﺤﺼﻮل ﻋﻠﻰ إرﺷﺎدات اﻻﺳﺘﺨﺪام، ﯾﺮﺟﻰ اﻻطﻼع ﻋﻠﻰ ﻗﺴﻢ &quot;اﻟﻤﻌﻠﻮﻣﺎت اﻟﺘﺎﻟﯿﺔ ﻣﻮﺟﮭﺔ إﻟﻰ ﻣﺘﺨﺼﺼﻲ اﻟﺮﻋﺎﯾﺔ اﻟﺼﺤﯿﺔ ﻓﻘﻂ&quot;.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إذا ﻛﻨﺖ تعتقد انك ﺗﺴﺘﺨﺪم فوكسيليوم أﻛﺜﺮ ﻣﻤﺎ ﯾﻨﺒﻐﻲ</strong></p><p dir="RTL">فوكسيليوم ھو منتج يتم استخدامه في المستشفيات ولا يتم إعطاؤه إلا من قبل المتخصصين في المجال الطبي فقط وسيتم مراقبة حالتك من حيث توازن السوائل وكيمياء الدم بعناية.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>لذلك</strong><strong> </strong><strong>فمن</strong><strong> </strong><strong>غير</strong><strong> </strong><strong>المرجح</strong><strong> </strong><strong>أن</strong><strong> </strong><strong>تستخدم</strong><strong> </strong><strong>فوكسيليوم</strong><strong> </strong><strong>بشكل</strong><strong> </strong><strong>أكثر</strong><strong> </strong><strong>مما</strong><strong> </strong><strong>ينبغي</strong></p><p dir="RTL">ﻓﻲ ﺣﺎﻟﺔ اﻟﺠﺮﻋﺔ اﻟﺰاﺋﺪة، وھﻮ أﻣﺮ ﻏﯿﺮ ﻣﺤﺘﻤﻞ، ﺳﯿﻘﻮم اﻟﻄﺒﯿﺐ ﺑﺎﺗﺨﺎذ اﻹﺟﺮاءات اﻟﺘﺼﺤﯿﺤﯿﺔ اﻟﻼزﻣﺔ وﺿﺒﻂ اﻟﺠﺮﻋﺔ.</p><p dir="RTL">ﻗﺪ ﯾﻨﺘﺞ ﻋﻦ اﻟﺠﺮﻋﺔ اﻟﺰاﺋﺪة:</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زﯾﺎدة اﻟﺴﻮاﺋﻞ ﻓﻲ اﻟﺪم ﻟﺪﯾﻚ،</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ارﺗﻔﺎع في ﻣﺴﺘﻮى ﺑﯿﻜﺮﺑﻮﻧﺎت اﻟﺪم (اﻟﻘﻼء اﻷﯾﻀﻲ)،</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; و/أو انخفاض في ﻣﺴﺘﻮﯾﺎت اﻷﻣﻼح ﻓﻲ اﻟﺪم (ﻧﻘﺺ ﻓﻮﺳﻔﺎت اﻟﺪم، ﻧﻘﺺ ﺑﻮﺗﺎﺳﯿﻮم اﻟﺪم).</p><p dir="RTL">&nbsp;</p><p dir="RTL">الجرعة الزائدة یمكن أن تؤدي إلى عواقب وخیمة، مثل قصور القلب الاحتقاني او اضطرابات في كيمياء الدم.</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا ﻛﺎﻧﺖ ﻟﺪﯾﻚ أي أﺳﺌﻠﺔ أﺧﺮى ﺣﻮل اﺳﺘﺨﺪام ھﺬا اﻟﺪواء، ﻓﺎﺳﺄل طﺒﯿﺒﻚ أو اﻟﺼﯿﺪﻟﻲ.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">إن ھﺬا اﻟﺪواء، ﻛﻐﯿﺮه ﻣﻦ اﻷدوﯾﺔ، ﻗﺪ ﯾﺘﺴﺒﺐ ﻓﻲ ﺣﺪوث آﺛﺎر ﺟﺎﻧﺒﯿﺔ، وﻟﻜﻦ ﻟﯿﺲ ﺑﺎﻟﻀﺮورة أن ﺗﺤﺪث ھﺬه اﻵﺛﺎر ﻟﻠﺠﻤﯿﻊ.</p><p dir="RTL">&nbsp;</p><p dir="RTL">من المحتمل حدوث الآثار الجانبية الثلاثة التالية <strong>المرتبطة</strong><strong> </strong><strong>باستخدام</strong><strong> </strong><strong>فوكسيليوم</strong>:</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ارﺗﻔﺎع أو اﻧﺨﻔﺎض ﺣﺠﻢ اﻟﻤﺎء ﺑﺸﻜﻞ ﻏﯿﺮ طﺒﯿﻌﻲ ﻓﻲ اﻟﺠﺴﻢ (ﻓﺮط أو ﻧﻘﺺ ﺣﺠﻢ اﻟﺪم)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ﺗﻐﯿﺮ ﻣﺴﺘﻮﯾﺎت اﻷﻣﻼح ﻓﻲ اﻟﺪم (اﺧﺘﻼل اﻟﺘﻮازن اﻹﻟﻜﺘﺮوﻟﯿﺘﻲ ﻣﺜﻞ ﻧﻘﺺ ﻓﻮﺳﻔﺎت اﻟﺪم، ﻧﻘﺺ ﺑﻮﺗﺎﺳﯿﻮم اﻟﺪم)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; رﻓﻊ ﺗﺮﻛﯿﺰ اﻟﺒﯿﻜﺮﺑﻮﻧﺎت ﻓﻲ اﻟﺒﻼزﻣﺎ (اﻟﻘﻼء اﻷﯾﻀﻲ) أو ﺗﻘﻠﯿﻞ ﺗﺮﻛﯿﺰ اﻟﺒﯿﻜﺮﺑﻮﻧﺎت ﻓﻲ اﻟﺒﻼزﻣﺎ (اﻟﺤﻤﺎض اﻷﯾﻀﻲ)</p><p dir="RTL">&nbsp;</p><p dir="RTL">ھناك أيضاً بعض الآثار الجانبية التي يمكن أن تحدث بسبب العلاج بالغسيل الكلوي، مثل:</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ﻏﺜﯿﺎن</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ﻗﻲء</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ﺗﺸﻨﺠﺎت اﻟﻌﻀﻼت</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اﻧﺨﻔﺎض ﺿﻐﻂ اﻟﺪم (ھﺒﻮط ﺿﻐﻂ اﻟﺪم)</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الإبلاغ عن الآثار الجانبية</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">في حالة تعرضك لأي آثار جانبية، تحدث إلى الطبيب أو الصيدلي أو الممرضة. يتضمن ذلك أي آثار جانبية محتملة غير مدرجة في هذه النشرة.</p><p dir="RTL">يمكنك أيضًا الإبلاغ مباشرة عن الآثار الجانبية من خلال: نظام الإبلاغ الوطني الوارد أدناه. بالإبلاغ عن الآثار الجانبية يمكنك المساعدة في توفير مزيد من المعلومات بشأن سلامة هذا الدواء.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>المملكة العربية السعودية:</strong></p><table dir="rtl" border="1" cellspacing="0" cellpadding="0" style="width:576px"><tbody><tr><td style="vertical-align:top"><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المركز الوطني للتيقظ والسلامة الدوائية (NPC)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مركز الاتصال التابع لهيئة الغذاء والدواء السعودية: 19999</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &rlm;‫البريد الإلكتروني: npc.drug@sfda.gov.sa</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &rlm;‫موقع الويب: https://ade.sfda.gov.sa/</p></td></tr></tbody></table><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>الامارات العربية المتحدة:</strong></p><p dir="RTL">&nbsp;</p><table dir="rtl" border="1" cellspacing="0" cellpadding="0" style="width:576px"><tbody><tr><td style="vertical-align:top"><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قسم التيقظ الدوائي والأجهزة الطبية</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; صندوق بريد: 1853</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; هاتف: 80011111</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &rlm;‫البريد الإلكتروني: &nbsp;pv@mohap.gov.ae</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &rlm;‫ادارة المستحضرات الدوائية</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; وزارة الصحة ووقاية المجتمع</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; دبي، الامارات العربية المتحدة</p></td></tr></tbody></table><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>دول مجلس التعاون الخليجي الأخرى:</strong></p><table dir="rtl" border="1" cellspacing="0" cellpadding="0" style="width:576px"><tbody><tr><td><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الرجاء الاتصال ﺑﺎﻟﻤﺆﺳﺴﺎت واﻟﮭﯿﺌﺎت اﻟﻮطﻨﯿﺔ المختصة ﻓﻲ ﻛﻞ دوﻟﺔ.</p></td></tr></tbody></table>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يحفظ بعيدًا عن رؤية ومتناول الأطفال</p><p dir="RTL">&nbsp;</p><p dir="RTL">ﻻ ﺗﺴﺘﺨﺪم ھﺬا اﻟﺪواء ﺑﻌﺪ ﺗﺎرﯾﺦ اﻧﺘﮭﺎء اﻟﺼﻼﺣﯿﺔ اﻟﻤﺬﻛﻮر ﻋﻠﻰ ظﮭﺮ اﻟﻜﯿﺲ وﻣﻠﺼﻖ اﻟﻌﺒﻮة ﺑﻌﺪ ﻛﻠﻤﺔ EXP (اﻧﺘﮭﺎء اﻟﺼﻼﺣﯿﺔ). ﯾﺸﯿﺮ ﺗﺎرﯾﺦ اﻧﺘﮭﺎء اﻟﺼﻼﺣﯿﺔ إﻟﻰ آﺧﺮ ﯾﻮم ﻣﻦ اﻟﺸﮭﺮ اﻟﻤﺬﻛﻮر.</p><p dir="RTL">&nbsp;</p><p dir="RTL">ﯾُﺨﺰن ﻓﻲ درﺟﺔ ﺣﺮارة ﻣﻦ 4 درﺟﺎت ﻣﺌﻮﯾﺔ إﻟﻰ 30 درﺟﺔ ﻣﺌﻮﯾﺔ. لا تقم بحفظه في الثلاجة أو تجميده.</p><p dir="RTL">&nbsp;</p><p dir="RTL">ﺗﻢ إﺛﺒﺎت اﺳﺘﻘﺮار اﻟﻤﻮاد اﻟﻜﯿﻤﯿﺎﺋﯿﺔ واﻟﻔﯿﺰﯾﺎﺋﯿﺔ اﻟﻤﺴﺘﺨﺪﻣﺔ ﻓﻲ اﻟﻤﺤﻠﻮل اﻟﺬي ﺗﻢ اﺳﺘﻨﺸﺎؤه ﻟﻤﺪة 24 ﺳﺎﻋﺔ ﻋﻨﺪ 22 درﺟﺔ ﻣﺌﻮﯾﺔ. وﻣﻦ وﺟﮭﺔ اﻟﻨﻈﺮ اﻟﻤﯿﻜﺮوﺑﯿﻮﻟﻮﺟﯿﺔ، ﯾﻔﻀﻞ اﺳﺘﺨﺪام اﻟﻤﺴﺘﻨﺸﺄ ﻋﻠﻰ اﻟﻔﻮر. إذا ﻟﻢ ﯾﺘﻢ اﺳﺘﺨﺪام اﻟﻤﺤﻠﻮل ﻓﻮ ًرا، ﻓﺈن أوﻗﺎت وظﺮوف اﻟﺘﺨﺰﯾﻦ ﻗﺒﻞ اﻻﺳﺘﺨﺪام ھﻲ ﻣﺴﺆوﻟﯿﺔ اﻟﻤﺴﺘﺨﺪم وﯾﺠﺐ أﻻ ﺗﺰﯾﺪ ﻋﻦ 24 ﺳﺎﻋﺔ ﺑﻤﺎ ﻓﻲ ذﻟﻚ ﻣﺪة اﻟﻌﻼج.</p><p dir="RTL">&nbsp;</p><p dir="RTL">لا تستخدم ھذا الدواء إذا كان المحلول غائما أو كانت العبوة المغلفة للمنتج تالفة. يجب أن تكون جميع الأكياس مغلقة بإحكام.</p><p dir="RTL">&nbsp;</p><p dir="RTL">ﻻ ﺗﻘﻢ ﺑﺎﻟﺘﺨﻠﺺ ﻣﻦ أي أدوﯾﺔ ﻓﻲ ﻣﯿﺎه اﻟﺼﺮف اﻟﺼﺤﻲ أو اﻟﻨﻔﺎﯾﺎت اﻟﻤﻨﺰﻟﯿﺔ. اﺳﺄل اﻟﺼﯿﺪﻟﻲ اﻟﺨﺎص ﺑﻚ ﻋﻦ ﻛﯿﻔﯿﺔ اﻟﺘﺨﻠﺺ ﻣﻦ اﻷدوﯾﺔ اﻟﺘﻲ ﻟﻢ ﺗﻌﺪ ﺗﺴﺘﺨﺪﻣﮭﺎ. ﺳﻮف ﺗﺴﺎﻋﺪ ھﺬه اﻟﺘﺪاﺑﯿﺮ ﻋﻠﻰ ﺣﻤﺎﯾﺔ اﻟﺒﯿﺌﺔ.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>ﻣﻜﻮﻧﺎت فوكسيليوم</strong></p><p dir="RTL">اﻟﻤﻮاد اﻟﻔﻌﺎﻟﺔ ﻗﺒﻞ وﺑﻌﺪ اعادة تركيب اﻟﻤﺤﻠﻮل:</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>اﻟﻤﻮاد اﻟﻔﻌﺎﻟﺔ ﻗﺒﻞ اعادة تركيب اﻟﻤﺤﻠﻮل:</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">1000 ﻣﻞ ﻣﻦ اﻟﻤﺤﻠﻮل <strong>ﻣﻦ اﻟﻘﺴﻢ اﻟﺼﻐﯿﺮ (</strong><strong>A</strong><strong>)</strong> ﺗﺤﺘﻮي ﻋﻠﻰ:</p><p dir="RTL">ﻜﺎﻟﺴﯿﻮم ﻛﻠﻮراﯾﺪ ﺛﻨﺎﺋﻲ اﻟﮭﯿﺪرات&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3.68 جرام</p><p dir="RTL">ﻤﻐﻨﯿﺴﯿﻮم ﻛﻠﻮراﯾﺪ ﺳﺪاﺳﻲ اﻟﮭﯿﺪرات&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2.44 جرام</p><p dir="RTL">&nbsp;</p><p dir="RTL">1000 ﻣﻞ ﻣﻦ اﻟﻤﺤﻠﻮل <strong>ﻣﻦ اﻟﻘﺴﻢ الكبير</strong> <strong>(</strong><strong>B</strong><strong>)</strong> ﺗﺤﺘﻮي ﻋﻠﻰ:</p><p dir="RTL">ﺼﻮدﯾﻮم كلورايد&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 6.44 جرام</p><p dir="RTL">ﻛﺮﺑﻮﻧﺎت اﻟﺼﻮدﯾﻮم اﻟﮭﯿﺪروﺟﯿﻨﯿﺔ&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2.92 جرام</p><p dir="RTL">كلورید البوتاسیوم&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.314 جرام</p><p dir="RTL">ثنائي الصوديوم فوسفات ثنائي الھيدرات&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.225 جرام</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>اﻟﻤﻮاد اﻟﻔﻌﺎﻟﺔ بعد اعادة تركيب اﻟﻤﺤﻠﻮل:</strong></p><p dir="RTL">ﯾﺘﻢ ﺧﻠﻂ اﻟﻤﺤﺎﻟﯿﻞ ﻣﻦ اﻟﻘﺴﻢ <strong>A</strong> (250 مللتر) ﻣﻊ اﻟﻤﺤﻠﻮل ﻣﻦ اﻟﻘﺴﻢ <strong>B</strong> (4750 مللتر) ﻟﻌﻤﻞ اﻟﻤﺤﻠﻮل المُعاد تركيبه (5000 مللتر) والذي ﯾﻜﻮن ﺗﺮﻛﯿﺒﮫ ﻛﺎﻟﺘﺎﻟﻲ:</p><table dir="rtl" border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p dir="RTL">&nbsp;</p></td><td style="vertical-align:top"><p dir="RTL"><strong>مليمول/لتر</strong></p></td></tr><tr><td style="vertical-align:top"><p dir="RTL">اﻟﻜﺎﻟﺴﯿﻮم، Ca<sup>2+</sup></p></td><td style="vertical-align:top"><p dir="RTL">1.25</p></td></tr><tr><td style="vertical-align:top"><p dir="RTL">اﻟﻤﻐﻨﯿﺴﯿﻮم، Mg<sup>2+</sup></p></td><td style="vertical-align:top"><p dir="RTL">0.6</p></td></tr><tr><td style="vertical-align:top"><p dir="RTL">ﺻﻮدﯾﻮم، Na<sup>+</sup></p></td><td style="vertical-align:top"><p dir="RTL">140</p></td></tr><tr><td style="vertical-align:top"><p dir="RTL">ﻛﻠﻮرﯾﺪ، Cl<sup>-</sup></p></td><td style="vertical-align:top"><p dir="RTL">115.9</p></td></tr><tr><td style="vertical-align:top"><p dir="RTL">فوسفات الهيدروجين، HPO<sub>4</sub><sup>2-</sup></p></td><td style="vertical-align:top"><p dir="RTL">1.2</p></td></tr><tr><td style="vertical-align:top"><p dir="RTL">كربونات هيدروجين، HCO<sub>3</sub><sup>-</sup></p></td><td style="vertical-align:top"><p dir="RTL">30</p></td></tr><tr><td style="vertical-align:top"><p dir="RTL">بوتاسيوم، K<sup>+</sup></p></td><td style="vertical-align:top"><p dir="RTL">4</p></td></tr></tbody></table><p dir="RTL">اﻷﺳﻤﻮﻟﯿﺔ اﻟﻨﻈﺮﯾﺔ: 293 ﻣﻠﻠﻲ أوﺳﻤﻮل/ﻟﺘﺮ.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>اﻟﻤﻜﻮﻧﺎت اﻷﺧﺮى ھﻲ</strong>:</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ﺛﺎﻧﻲ أﻛﺴﯿﺪ اﻟﻜﺮﺑﻮن (لضبط درجة الحوضة pH) E290</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حمض الهيدروكوريك (لضبط درجة الحوضة pH) E507</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; وﻣﺎء ﻟﻠﺤﻘﻦ.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>ﻛﯿﻒ ﯾﺒﺪو فوكسيليوم وﻣﺎ ھي ﻣﺤﺘﻮﯾﺎت اﻟﻌﺒﻮة </strong></p><p dir="RTL">فوكسيليوم ھو محلول للغسيل الكلوى ﯾﺄﺗﻲ ﻓﻲ ﻛﯿﺲ مكوّن من ﻗﺴﻤﯿﻦ. ﯾﺘﻢ اﻟﺤﺼﻮل ﻋﻠﻰ اﻟﻤﺤﻠﻮل اﻟﻨﮭﺎﺋﻲ المعاد تركيبه ﺑﻌﺪ ﻧﺰع ﺧﺘﻢ اﻹﻏﻼق وﻣﺰج ﻛﻼ اﻟﻤﺤﻠﻮﻟﯿﻦ. ﯾﻜﻮن اﻟﻤﺤﻠﻮل المعاد تركيبه ﺷﻔﺎﻓًﺎ وعديم اللون. ﻛﻞ ﻛﯿﺲ ﺑﮫ ﻗﺴﻤﯿﻦ (A+B) ﯾﺤﺘﻮي ﻋﻠﻰ ﻣﺤﻠﻮل 5000 ﻣللتر ﻟﻼﺳﺘﺨﺪام ﻓﻲ ﺗﻨﻘﯿﺔ اﻟﺪم وﺗﺮﺷﯿﺢ اﻟﺪم و/أو اﻟﻐﺴﯿﻞ اﻟﻜﻠﻮى. اﻟﻜﯿﺲ ﻣﻐﻠﻒ ﺑﻐﻼف رﻗﯿﻖ ﺷﻔﺎف.</p><p dir="RTL">يحتوي ﻛﻞ كرتون ﻋﻠﻰ ﻛﯿﺴﯿﻦ وﻧﺸﺮة واﺣﺪة داﺧﻠﯿﺔ.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>حامل ترخيص التسويق والمصانع</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">حامل ترخيص التسويق:</p><p dir="RTL">&nbsp;</p><p>Baxter Holding B.V.</p><p>Kobaltweg 49</p><p>3542CE Utrecht</p><p>The Netherland</p><p dir="RTL">يتم تصنيعه في:</p><p dir="RTL">&nbsp;</p><p>Bieffe Medital S.p.A.,</p><p>Via Stelvio 94,</p><p>23035 Sondalo (SO),</p><p>Italy</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تمت مراجعة هذه النشرة آخر مرة في مارس 2023.
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                PHOXILIUM 1.2 mmol/l phosphate Solution for haemodialysis/ haemofiltration
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Phoxilium is presented in a two-compartment bag. The final reconstituted solution is obtained after breaking the frangible pin or the peel seal and mixing both solutions.

BEFORE RECONSTITUTION
1000 ml of solution in the small compartment (A) contains:
Calcium chloride, 2 H2O	                3.68 g
Magnesium chloride, 6 H2O	                2.44 g

1000 ml of solution in the large compartment (B) contains:
Sodium chloride			     6.44 g
Sodium hydrogen carbonate 		     2.92 g
Potassium chloride			     0.314 g
Disodium phosphate, 2 H2O   	 0.225 g

AFTER RECONSTITUTION
1000 ml of the reconstituted solution contains:

-	Active substances	mmol/l	mEq/l
-	Calcium 	Ca2+	1.25	2.50
-	Magnesium 	Mg2+	0.600	1.20
-	Sodium 	Na+	140.0	140.0
-	Chloride 	Cl-	115.9	115.9
-	Hydrogen phosphate	HPO42-	1.20 	2.40
-	Hydrogen carbonate	HCO3-	30.0	30.0
-	Potassium 	K+	4.00	4.00
		

Each 1000 ml of the final reconstituted solution corresponds to 50 ml of solution A and 950 ml of solution B.

For the full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Solution for haemodialysis/ haemofiltration.
Clear and colourless solutions.

Theoretical osmolarity: 293 mOsm/l
pH of the reconstituted solution: 7.0 – 8.5
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Phoxilium is used for CRRT (continuous renal replacement therapy) in critically ill patients with ARF (acute renal failure) when pH and kalaemia have been restored to normal and when the patients need phosphate supplementation for loss of phosphate in the ultrafiltrate or to the dialysate during CRRT.</p><p>&nbsp;</p><p>Phoxilium may also be used in cases of drug poisoning or intoxications when the poisons are dialysable or pass through the membrane.</p><p>&nbsp;</p><p>Phoxilium is indicated for use in patients with normal kalaemia and normal or hypophosphataemia.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Posology:</p><p>The volume and rate at which Phoxilium is administered depends on the blood concentration of phosphate and other electrolytes, acid&ndash;base balance, fluid balance and overall clinical condition of the patient. The volume of replacement solution and/or dialysate to be administered will also depend on the desired intensity (dose) of the treatment. Administration (dose, infusion rate and cumulative volume) of Phoxilium should only be established by a physician experienced in critical care medicine and CRRT (Continuous Renal Replacement Therapy).</p><p>&nbsp;</p><p>The dose volume is therefore at the discretion and prescription of the responsible physician.</p><p>&nbsp;</p><p>The range of flow rates for the replacement solution in haemofiltration and haemodiafiltration are:</p><p>Adult:&nbsp; 500 - 3000 ml/hour</p><p>&nbsp;</p><p>The range of flow rates for the dialysate in continuous haemodialysis and continuous haemodiafiltration are:</p><p>Adult:&nbsp; 500 - 2500 ml/hour</p><p>&nbsp;</p><p>Commonly used combined total flow rates for CRRT (dialysate and replacement solutions) in adults are approximately 2000 to 2500 ml/h which correspond to a daily fluid volume of approximately 48 to 60 l.</p><p>&nbsp;</p><p>Paediatric population:</p><p><strong>&nbsp;</strong></p><p>In children from neonates to adolescents to 18 years, the range of flow rates used as substitution solution in haemofiltration and haemodiafiltration and as dialysis solution (dialysate) in continuous haemodialysis and continuous haemodiafiltration are 1000 to 4000 ml/h/1.73 m<sup>2</sup>.</p><p>For adolescents (12-18 years), the adult dose recommendation should be used when the paediatric dose is calculated to exceed the maximum adult dose.</p><p>&nbsp;</p><p>Method of administration:</p><p>Intravenous use and for haemodialysis.</p><p>&nbsp;</p><p>Phoxilium, when used as a replacement solution is administered into the extracorporeal circuit before (pre-dilution) or after the haemofilter or haemodiafilter (post-dilution).</p><p>Phoxilium, when used as a dialysate, it is administered in the dialysate compartment of the extracorporeal filter separated from the blood flow by a semipermeable membrane.</p><p>&nbsp;</p><p>For instructions on reconstitution of the medicinal product before administration, see section 6.6.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to the active substance(s) or to any of the excipients listed in section 6.1.

Solution dependent contraindications
•	Hyperkalaemia
•	Metabolic alkalosis
•	Hyperphosphataemia

Haemofiltration/- dialysis dependent contraindications
•	Renal failure with pronounced hypercatabolism, if the uraemic symptoms cannot be corrected with haemofiltration or haemodiafiltration,
•	Insufficient arterial pressure in the vascular access,
•	Systemic anticoagulation if there is a high risk of haemorrhage. 
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The solution shall be used only by, or under the direction of, a physician competent in CRRT treatments using haemofiltration, haemodiafiltration and haemodialysis.</p><p>&nbsp;</p><p>Warnings:</p><p>&nbsp;</p><p>Phoxilium should not be used in patients with hyperkalemia (see section 4.3). The serum potassium concentration must be monitored before and during haemofiltration and/or haemodialysis.</p><p>&nbsp;</p><p>Because Phoxilium is a potassium-containing solution, hyperkalaemia may occur transiently after treatment is initiated. Decrease the infusion rate and confirm that the desired potassium concentration is achieved. If hyperkalaemia does not resolve, stop administration promptly.</p><p>&nbsp;</p><p>If hyperkalaemia develops when Phoxilium is used as a dialysate, administration of a potassium-free dialysate may be necessary to increase the rate of potassium removal.</p><p>&nbsp;</p><p>Because Phoxilium is a phosphate-containing solution, hyperphosphatemia may occur transiently after treatment is initiated.&nbsp; Decrease the infusion rate and confirm that the desired phosphate concentration is achieved.&nbsp; If hyperphosphatemia does not resolve, stop administration promptly (See Section 4.3 Contraindication).</p><p><em>&nbsp;</em></p><p>Electrolyte and blood acid/base parameters should be monitored regularly in patients treated with Phoxilium. &nbsp;Phoxilium contains hydrogen phosphate, a weak acid that can influence the patient&rsquo;s acid/base balance.&nbsp; If metabolic acidosis develops or worsens during therapy with Phoxilium, the infusion rate may need to be decreased or its administration stopped.&nbsp;</p><p>&nbsp;</p><p>Because Phoxilium contains no glucose, administration may lead to hypoglycaemia.&nbsp;Blood glucose levels should be monitored regularly in diabetic patients (including careful consideration of patients receiving insulin or other glucose lowering medications), but also considered in non-diabetic patients, e.g. risk for silent hypoglycemia during the procedure.&nbsp;If hypoglycaemia develops, use of a glucose-containing solution should be considered. Other corrective measures may be necessary to maintain desired glycaemic control.</p><p>&nbsp;</p><p>The instructions for use (see section 6.6) must be strictly followed.</p><p>The solutions in the two compartments must be mixed before use.</p><p>&nbsp;Use of a contaminated solution may cause sepsis and shock</p><p>&nbsp;</p><p>Do not administer the solution unless it is clear. Aseptic technique must be used during connection / disconnection of the line sets to the Phoxilium container.</p><p>&nbsp;</p><p>Use only with an appropriate extracorporal renal replacement equipment.</p><p>&nbsp;</p><p>Special precautions for use:</p><p>Phoxilium may be warmed to 37 &deg;C to enhance patient comfort. Warming of the solution prior to use should be done before reconstitution with dry heat only. Solutions should not be heated in water or in a microwave oven. Phoxilium should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. Do not administer unless the solution is clear and the seal is intact.</p><p>&nbsp;</p><p>Haemodynamic status, fluid balance, electrolyte and acid-base balance shall be closely monitored throughout the procedure including all fluid inputs and outputs, even those not directly related to CRRT.</p><p>&nbsp;</p><p>In case of hypervolaemia, the net ultrafiltration rate prescribed for the CRRT device can be increased and/or the rate of administration of solutions other than replacement fluid and/or dialysate can be reduced.</p><p>&nbsp;</p><p>In case of hypovolaemia, the net ultrafiltration rate prescribed for the CRRT device can be reduced and/or the rate of administration of solutions other than replacement fluid and/or dialysate can be increased.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The blood concentration of filterable/dialysable drugs may be reduced during treatment due to their removal by the haemodialyser, haemofilter or haemodiafilter. Corresponding corrective therapy should be instituted if necessary to establish the correct doses for drugs removed during the &nbsp;treatment.</p><p>Interactions with other medications can be avoided by correct dosage of the solution for haemofiltration and haemodialysis.</p><p>&nbsp;</p><p>The following are examples of potential drug interactions with Phoxilium:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Additional sources of phosphate (e.g., hyperalimentation fluid) may influence serum phosphate concentration&nbsp; and may increase the risk of&nbsp; hyperphosphatemia,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Vitamin D and other vitamin D analogues, as well as medicinal products containing calcium (e.g. calcium chloride or calcium gluconate used for maintenance of calcium homeostasis in CRRT patients receiving citrate anticoagulation) can increase the risk of hypercalcaemia,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Additional sodium bicarbonate (or buffer source) contained in the CRRT fluids or in other fluids may increase the risk of metabolic alkalosis.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; When citrate is used as an anticoagulant, it contributes to the overall buffer load and can reduce plasma calcium levels.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Fertility</p><p>No effects on fertility are anticipated, since calcium, sodium, potassium, magnesium, chloride, hydrogen phosphate and hydrogen carbonate are normal constituents of the body.</p><p>&nbsp;</p><p>Pregnancy and lactation</p><p>There are no documented clinical data on the use of Phoxilium during pregnancy and lactation. Phoxilium should only be administered to pregnant and lactating women if clearly needed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not relevant</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Undesirable effects can result from the solution used or the treatment.</p><p>&nbsp;</p><p>Bicarbonate-buffered haemofiltration and haemodialysis solutions are generally well tolerated.</p><p>&nbsp;</p><p>The following undesirable effects have been reported from post-marketing experience. The table presented below is according to the MedDRA system organ classification (SOC and Preferred Term Level). Frequencies cannot be estimated from the available data.</p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>MedDra System Organ Class</p></td><td style="vertical-align:top"><p>Preferred Term</p></td><td style="vertical-align:top"><p>Frequency</p></td></tr><tr><td rowspan="3" style="vertical-align:top"><p>Metabolism and nutrition disorders</p></td><td style="vertical-align:top"><p>Electrolyte imbalances, e.g.:, hyperphosphataemia</p></td><td style="vertical-align:top"><p>not known</p></td></tr><tr><td style="vertical-align:top"><p>Fluid imbalance, e.g.: hypervolaemia, hypovolaemia</p></td><td style="vertical-align:top"><p>not known</p></td></tr><tr><td style="vertical-align:top"><p>Acid-base balance disorders, e.g. metabolic acidosis, metabolic alkalosis</p></td><td style="vertical-align:top"><p>not known</p></td></tr><tr><td style="vertical-align:top"><p>Vascular disorder</p></td><td style="vertical-align:top"><p>Hypotension*</p></td><td style="vertical-align:top"><p>not known</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>Gastrointestinal disorder</p></td><td style="vertical-align:top"><p>Nausea*</p></td><td style="vertical-align:top"><p>not known</p></td></tr><tr><td style="vertical-align:top"><p>Vomiting*</p></td><td style="vertical-align:top"><p>not known</p></td></tr><tr><td style="vertical-align:top"><p>Musculoskeletal and connective tissue disorders</p></td><td style="vertical-align:top"><p>Muscle cramps*</p></td><td style="vertical-align:top"><p>not known</p></td></tr></tbody></table><p>* undesirable effects related generally to dialysis treatments.</p><p>&nbsp;</p><p>&nbsp;</p><p><u>Reporting of suspected adverse reactions</u></p><p>Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system listed below.</p><p>&nbsp;</p><p><strong>To report any side effect(s):</strong></p><p>&nbsp;</p><ul><li><strong>Saudi Arabia:</strong></li></ul><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0" style="width:588px"><tbody><tr><td style="vertical-align:top"><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The National Pharmacovigilance Centre (NPC)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SFDA Call Center: 19999</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; E-mail: npc.drug@sfda.gov.sa&nbsp;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Website: https://ade.sfda.gov.sa/ <u>&nbsp;</u>&nbsp;</p></td></tr></tbody></table><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Other GCC States:</strong></p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0" style="width:588px"><tbody><tr><td><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Please contact the relevant competent authority.</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Overdose with Phoxilium should not occur if the procedure is carried out correctly and the fluid balance, electrolyte and acid-base balance of the patient is carefully monitored by trained medical personnel.</p><p>However, Phoxilium overdose can lead to severe clinical conditions, such as congestive heart failure, electrolyte or acid-base disturbances.</p><p>If hypervolaemia or hypovolaemia occur, instruction for handling of hypervolaemia or hypovolaemia in section 4.4 must be strictly followed.</p><p>If metabolic acidosis and/or hyperphosphatemia occur, stop administration promptly. There is no specific antidote for overdose. The risk can be minimized by close monitoring during treatment (see section 4.3 and 4.4).</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Hemofiltrates.</p><p>ATC code: B05ZB</p><p>&nbsp;</p><p>Phoxilium, solution for haemofiltration and haemodialysis, is pharmacologically inactive. The sodium, calcium, magnesium, potassium, phosphate and chloride ions are present at concentrations similar to physiological concentrations in normal plasma.</p><p>Phoxilium is used to replace water and electrolytes removed during haemofiltration and haemodiafiltration or to serve as a suitable dialysate for use during continuous haemodiafiltration or continuous haemodialysis.</p><p>Hydrogen carbonate is used as an alkalising buffer.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not relevant.</p><p>The active ingredients in Phoxilium are pharmacologically inactive and are present at concentrations similar to physiological plasma concentrations.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No relevant data from preclinical findings. The active ingredients are pharmacologically inactive and are present at concentrations similar to physiological plasma levels.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Small compartment A: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Water for injections</p><p>Hydrochloric acid (for pH adjustment)</p><p>Large compartment B:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Water for injections</p><p>Carbon dioxide (for pH adjustment)</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In the absence of compatibility studies, this medicinal product must not be mixed with other medicinal products.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                18 months 

After reconstitution:
Chemical and physical in-use stability of the reconstituted solution has been demonstrated for 24 hours at 22oC. If not used immediately, in-use storage times and conditions prior to use are the responsibility of the user and would not normally be longer than 24 hours including the duration of the treatment.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store between +4&deg;C and +30&deg;C.</p><p>Do not refrigerate or freeze.</p><p>For the storage condition of the reconstituted solution, see section 6.3.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The container made in polyvinyl chloride (PVC) or polyolefin is a two-compartment bag. The 5000 ml bag is comprised of a small compartment (250 ml) and a large compartment (4750 ml). The two compartments are separated by a frangible pin or a peel seal.</p><p>The large compartment B is fitted with an injection connector (or spike connector) made of polycarbonate (PC), which is closed with a rubber disc covered by a cap as well as a luer connector (PC) with a frangible pin (PC) or a valve made of silicone rubber for the connection of the bag with a suitable replacement solution&nbsp;line or&nbsp;dialysis line.</p><p>The bag is over wrapped with a transparent overwrap made of a multilayer polymer film.</p><p>&nbsp;</p><p>Each two-compartment bag contains 5000 ml.</p><p>Package size: 2 x 5000 ml in a box.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The solution in the small compartment A is added to the solution in the large compartment B after breaking the frangible pin or the peel seal immediately before use. The reconstituted solution shall be clear and colourless.</p><p>&nbsp;</p><p>A package leaflet with detailed instruction for use is enclosed in the box.</p><p>&nbsp;</p><p>Aseptic technique shall be used throughout the handling and administration to the patient.</p><p>Use only if the overwrap is undamaged, all seals are intact, frangible pin or peel seal is not broken, and the solution is clear. Press bag firmly to test for any leakage. If leakage is discovered, discard the solution immediately since sterility can no longer be assured.</p><p>&nbsp;</p><p>The large compartment B is fitted with an injection port for the possible addition of other necessary drugs after reconstitution of the solution. &nbsp;It is the responsibility of the user to judge the compatibility of an additive medication with Phoxilium by checking for eventual colour change and/or eventual precipitation, insoluble complexes or crystals. Before adding a medication, verify if it is soluble and stable in this medicine and that the pH range of Phoxilium is appropriate (pH of reconstituted solution is 7.0&ndash;8.5). Additives may be incompatible. The Instructions for Use of the medication to be added must be consulted.</p><p>&nbsp;</p><p>Remove any fluid from the injection port, hold the bag upside down, insert the drug through the injection port and mix thoroughly. The introduction and mixing of additives must always be performed prior to connecting the solution bag to the extracorporeal circuit. The solution must be administered immediately.</p><p>If a frangible pin separates the two compartments of the bag and a frangible pin is located in the luer connector the following instructions for use shall be followed:</p><p>I &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Remove the over wrap from the bag immediately before use and discard any other packaging materials. Open the seal by breaking the frangible pin between the two compartments of the bag. The frangible pin will remain in the bag.</p><p>II &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Make sure all the fluid from the small compartment A is transferred into the large compartment B.</p><p>III &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Rinse the small compartment A twice by pressing the mixed solution back into the small compartment A and then back into the large compartment B.</p><p>IV &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; When the small compartment A is empty: shake the large compartment B so that the contents mix completely. The solution is now ready for use and the bag can be hung on the equipment.</p><p>V&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The dialysis or replacement line may be connected to either of the two access ports.</p><p>Va&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If the luer access is used, using aseptic technique, remove the cap and connect the male luer lock on the dialysis or replacement line to the female luer receptor on the bag: tighten. Using both hands, break the blue frangible pin at its base, and move it back and forth. Do not use a tool. Verify that the pin is completely separated and that the fluid is flowing freely. The pin will remain in the luer port during the treatment.</p><p>Vb&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If the injection port is used, first remove the snap-off cap. The injection port is a swabbable port. Then introduce the spike through the rubber septum. Verify that the fluid is flowing freely. &nbsp;&nbsp;</p><p>&nbsp;</p><p>If a frangible pin separates the two compartments of the bag and a valve is located in the luer connector the following instructions for use shall be followed:</p><p>I &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Remove the over wrap from the bag immediately before use and discard any other packaging materials. Open the seal by breaking the frangible pin between the two compartments of the bag. The frangible pin will remain in the bag.</p><p>II &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Make sure all the fluid from the small compartment A is transferred into the large compartment B.</p><p>III &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Rinse the small compartment A twice by pressing the mixed solution back into the small compartment A and then back into the large compartment B.</p><p>IV &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; When the small compartment A is empty: shake the large compartment B so that the contents mix completely. The solution is now ready for use and the bag can be hung on the equipment.</p><p>V&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The dialysis or replacement line may be connected to either of the two access ports.</p><p>Va&nbsp;&nbsp;&nbsp;&nbsp; If the luer access is used, remove the cap with a twist and pull motion, and connect the male luer lock on the dialysis or replacement line to the female luer receptor on the bag using a push and twist motion. Ensure that the connection is fully seated and tighten. The connector is now open. Verify that the fluid is flowing freely.</p><p>When the dialysate or replacement line is disconnected from the luer connector, the connector will close and the flow of the solution will stop. The luer port is a needle-less and swabbable port.</p><p>Vb&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If the injection port is used, first remove the snap-off cap. The injection port is a swabbable port. Then introduce the spike through the rubber septum. Verify that the fluid is flowing freely.</p><p>&nbsp;</p><p>If a peel seal separates the two compartments of the bag and a valve is located in the luer connector the following instructions for use shall be followed:</p><p><strong>I &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>Remove the over wrap from the bag immediately before use and discard any other packaging materials. Open the seal by holding the small compartment with both hands and squeezing it until an opening is created in the peel seal between the two compartments.</p><p>II &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Push with both hands on the large compartment until the peel seal between the two compartments is entirely open.</p><p><strong>III&nbsp;&nbsp;&nbsp;&nbsp; </strong>Secure complete mixing of the solution by shaking the bag gently. The solution is now ready for use, and can be hung on the equipment.</p><p><strong>IV&nbsp;&nbsp;&nbsp;&nbsp; </strong>The dialysis or replacement line may be connected to either of the two access ports.</p><p><strong>IVa&nbsp;&nbsp; </strong>If the luer access is used, remove the cap with a twist and pull motion, and connect the male luer lock on the dialysis or replacement line to the female luer receptor on the bag using a push and twist motion. Ensure that the connection is fully seated and tighten. The connector is now open. Verify that the fluid is flowing freely.</p><p>When the dialysis or replacement line is disconnected from the luer connector, the connector will close and the flow of the solution will stop. The luer port is a needle-less and swabbable port.</p><p><strong>IVb&nbsp;&nbsp; </strong>If the injection port is used, first remove the snap-off cap. The injection port is a swabbable port. Then introduce the spike through the rubber septum. Verify that the fluid is flowing freely</p><p>&nbsp;</p><p>The reconstituted solution shall be used immediately. If not used immediately, the reconstituted solution should be used within 24 hours including the duration of the treatment after addition of the solution A to solution B.</p><p>&nbsp;</p><p>The reconstituted solution is for single use only.</p><p>Discard any unused solution immediately after use.</p><p>&nbsp;</p><p>Any unused medicinal product or waste material should be disposed of in accordance with local requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Baxter Holding B.V.
Kobaltweg 49
3542CE Utrecht
The Netherland
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                March 2023
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>